Article
The Predictive Effect of Tumor Mutation Burden on prognosis in Breast cancer: A Systematic Review and Meta-Analysis
2022-09-20
Abstract excerpt
<h4>Background: </h4> Tumor mutation burden ( TMB ), as a promising predictive factor, has made some progress in predicting response to immune checkpoint inhibitors ( ICIs ) in several cancer types. The association between TMB and the clinical efficacy of ICIs in breast cancer has no conclusion. And it is controversial that whether TMB plays different forecast effects of ICIs and non-ICIs treatment. In this study,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 75816058-0761-5181-a52f-8604da0a583c
- DOI
- 10.21203/rs.3.rs-2043934/v1
